Guidance on PFAS Testing and Health Outcomes Meeting 6

August 11, 2021

Per- and polyfluoroalkyl substances (PFAS) are chemicals with almost ubiquitous exposure in the US—leading to concerns about who should be tested for exposure to PFAS and then if testing occurs, how those results should inform clinical care. The Agency for Toxic Substances and Disease Registry and the National Institute of Environmental Health Sciences have sponsored a study that will provide advice for clinicians about PFAS testing, such as when to test, whom to test, how to test, what to test for, and the risks of testing. In this meeting, the committee will hear from experts on general principles for clinical evaluation and biological testing.

Day 1(8/11) will begin at 1:25 PM ET and end at 4:05 PM ET

Day 2 (8/12) will begin at 1:00 PM ET and end at 2:25 PM ET

There will be no public chat box during the webcast; please use the email address listed below if you wish to contact us.

[email protected]

If you require technical assistance for the webinar, please follow the link below:


Learn more here